R, J., DW, S., CM, F., T, C., JMM, C., Q, L., . . . RJ, M. (2021). The prostaglandin pathway is activated in patients who fail medical therapy for benign prostatic hyperplasia with lower urinary tract symptoms. The Prostate, 81(13), 944. https://doi.org/10.1002/pros.24190
Chicago Style (17th ed.) CitationR, Jin, et al. "The Prostaglandin Pathway Is Activated in Patients Who Fail Medical Therapy for Benign Prostatic Hyperplasia with Lower Urinary Tract Symptoms." The Prostate 81, no. 13 (2021): 944. https://doi.org/10.1002/pros.24190.
MLA (9th ed.) CitationR, Jin, et al. "The Prostaglandin Pathway Is Activated in Patients Who Fail Medical Therapy for Benign Prostatic Hyperplasia with Lower Urinary Tract Symptoms." The Prostate, vol. 81, no. 13, 2021, p. 944, https://doi.org/10.1002/pros.24190.